help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Damon, S. E.
Right arrow Articles by Roberts, C. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Damon, S. E.
Right arrow Articles by Roberts, C. T., Jr.
Endocrinology Vol. 142, No. 1 21-27
Copyright © 2001 by The Endocrine Society


ARTICLES

Transcriptional Regulation of Insulin-Like Growth Factor-I Receptor Gene Expression in Prostate Cancer Cells1

Susan E. Damon, Stephen R. Plymate, Julie M. Carroll, Cynthia C. Sprenger, Chevaboon Dechsukhum, Joy L. Ware and Charles T. Roberts, Jr.

Geriatric Research Education and Clinical Center, Veterans Administration Puget Sound Health Care System (S.E.D., C.C.S., S.R.P.), Tacoma, Washington 98493; Department of Medicine, University of Washington (S.E.D., S.R.P.), Seattle, Washington 98195; Department of Pathology, Medical College of Virginia/Virginia Commonwealth University (C.D., J.L.W.), Richmond, Virginia 23298; and Department of Pediatrics, Oregon Health Sciences University (J.M.C., C.T.R.), Portland, Oregon 97201

Address all correspondence and requests for reprints to: Dr. Charles T. Roberts, Department of Pediatrics (NRC-5), Oregon Health Sciences University, 3181 SW Sam Jackson Park Road, Portland, Oregon 97201. E-mail: robertsc{at}ohsu.edu

A marked decrease in the type 1 insulin-like growth factor (IGF) receptor (IGF-IR) occurs in prostate epithelial cells during transformation from the benign to the metastatic state. One of the principal regulators of IGF-IR gene expression, the WT1 tumor suppressor, is expressed in prostate cancer and in prostate cancer cell lines. The purpose of this study was to determine whether the decrease in IGF-IR expression was transcriptionally regulated, and whether WT1 action may be involved in the repression of the IGF-IR gene in prostate cancer cells. The P69 cell line was derived by immortalization of human primary prostate epithelial cells with simian virus-40 T antigen and is rarely tumorigenic. The M12 line was derived from the P69 line by selection for tumor formation in nude mice and is tumorigeneic and metastatic. P69 cells express 20,000 IGF-IR/cell, whereas M12 cells express 3,500 IGF-IR/cell. These differences in receptor number are reflected in proportional differences in IGF-IR mRNA levels. To assess IGF-IR promoter activity in these cell lines, each was transiently transfected with luciferase reporter vectors containing the IGF-IR gene transcription start site and 476 bp of 5'-flanking sequence, 640 bp of 5'-untranslated region sequence, or both regions. The promoter activity of the full-length construct was 50% lower (P < 0.01) in M12 cells compared with P69 cells, the activity of the 5'-flanking region construct was 53% lower (P < 0.0001), and that of the 5'-untranslated region construct was 36% lower (P = 0.01). P69 clones stably transfected with a WT1 expression vector exhibited decreased expression of the endogenous IGF-IR gene and decreased promoter activity in transient transfection assays with IGF-IR promoter constructs containing multiple WT1 binding sites. The observed reduction in endogenous IGF-IR expression was sufficient to inhibit IGF-I-stimulated cell proliferation. These data suggest that most of the decreased expression of the IGF-IR seen in malignant prostate epithelium is the result of transcriptional repression of the IGF-IR gene, and that this repression may be due in part to the increased expression of the WT1 tumor suppressor in metastatic prostate cancer.




This article has been cited by other articles:


Home page
Cancer Res.Home page
T. R. Graham, H. E. Zhau, V. A. Odero-Marah, A. O. Osunkoya, K. S. Kimbro, M. Tighiouart, T. Liu, J. W. Simons, and R. M. O'Regan
Insulin-like Growth Factor-I-Dependent Up-regulation of ZEB1 Drives Epithelial-to-Mesenchymal Transition in Human Prostate Cancer Cells
Cancer Res., April 1, 2008; 68(7): 2479 - 2488.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
G. Pandini, M. Genua, F. Frasca, S. Squatrito, R. Vigneri, and A. Belfiore
17{beta}-Estradiol Up-regulates the Insulin-like Growth Factor Receptor through a Nongenotropic Pathway in Prostate Cancer Cells
Cancer Res., September 15, 2007; 67(18): 8932 - 8941.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
G. Pandini, R. Mineo, F. Frasca, C. T. Roberts Jr., M. Marcelli, R. Vigneri, and A. Belfiore
Androgens Up-regulate the Insulin-like Growth Factor-I Receptor in Prostate Cancer Cells
Cancer Res., March 1, 2005; 65(5): 1849 - 1857.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
M. Rubinstein, G. Idelman, S. R. Plymate, G. Narla, S. L. Friedman, and H. Werner
Transcriptional Activation of the Insulin-Like Growth Factor I Receptor Gene by the Kruppel-Like Factor 6 (KLF6) Tumor Suppressor Protein: Potential Interactions between KLF6 and p53
Endocrinology, August 1, 2004; 145(8): 3769 - 3777.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
S. Wang, V. L. DeGroff, and S. K. Clinton
Tomato and Soy Polyphenols Reduce Insulin-Like Growth Factor-I-Stimulated Rat Prostate Cancer Cell Proliferation and Apoptotic Resistance In Vitro via Inhibition of Intracellular Signaling Pathways Involving Tyrosine Kinase
J. Nutr., July 1, 2003; 133(7): 2367 - 2376.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
H. Pizzi, J. Gladu, L. Carpio, D. Miao, D. Goltzman, and S. A. Rabbani
Androgen Regulation of Parathyroid Hormone-Related Peptide Production in Human Prostate Cancer Cells
Endocrinology, March 1, 2003; 144(3): 858 - 867.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
T. Nickerson, F. Chang, D. Lorimer, S. P. Smeekens, C. L. Sawyers, and M. Pollak
In Vivo Progression of LAPC-9 and LNCaP Prostate Cancer Models to Androgen Independence Is Associated with Increased Expression of Insulin-like Growth Factor I (IGF-I) and IGF-I Receptor (IGF-IR)
Cancer Res., August 1, 2001; 61(16): 6276 - 6280.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
P. Ostlund, H. Lindegren, C. Pettersson, and K. Bedecs
Up-regulation of Functionally Impaired Insulin-like Growth Factor-1 Receptor in Scrapie-infected Neuroblastoma Cells
J. Biol. Chem., September 21, 2001; 276(39): 36110 - 36115.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2001 by The Endocrine Society